A Landmark Study: Green Tea and Spike Proteins

As we enter the fall season, an important concern of your clients may arise about what they can do to effectively support and protect their immune systems, especially during the upcoming cold winter season.

While practitioners aptly continue to recommend effective foundational nutritional support for the immune system, including plant-source vitamin C, nature-sourced vitamin D (not synthetic versions) and liquid-based, highly absorbable zinc, research has now uncovered another highly beneficial agent for immune support in relationship to spike proteins. It’s our old friend, green tea, and its characteristic, immune-promoting EGCG content.

In a recent research study published in Cell and BioScience (2021), researchers have found that EGCG (epigallocatechin gallate) from green tea is capable of effectively blocking infection of SARS-COV-2 due to its ability to inhibit the spike protein from binding to the ACE2 receptor.

To view this land-mark study entitled, “Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor,” you may find it here.

These research findings present practitioners with another substantial agent to address their client’s top immune concerns, including potential new variants that may arise. The researchers concluded: “These data support further clinical evaluation and development of EGCG [in green tea] as a novel, safe, and cost-effective natural product” and which can be beneficially used by practitioners to address potential immune concerns of their clients.